Pemberton, N, Mogemark, M, Arlbrandt, S , Bold, P, Cox, RJ, Gardelli, C, Holden, Neil, Karabelas, K, Karlsson, J, Lever, J, Li, X, Lindmark, H, Norberg, M, Perry, MWD, Petersen, J, Rodrigo Blomqvist, S, Thomas, M, Tyrchan, C, Westin Eriksson, A, Zlatoidsky, P and Öster, L (2018) Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors. Journal of Medicinal Chemistry, 61 (12). pp. 5435-5441. ISSN 0022-2623
Full content URL: http://doi.org/10.1021/acs.jmedchem.8b00447
| Documents |
| ||||
![[img]](http://eprints.lincoln.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
acs.jmedchem.8b00447.pdf - Whole Document 1MB |
| Item Type: | Article |
|---|---|
| Item Status: | Live Archive |
Abstract
In this paper, we describe the discovery and optimization of a new chemotype of isoform selective PI3Kγ inhibitors. Starting from an HTS hit, potency and physicochemical properties could be improved to give compounds such as 15, which is a potent and remarkably selective PI3Kγ inhibitor with ADME properties suitable for oral administration. Compound 15 was advanced into in vivo studies showing dose-dependent inhibition of LPS-induced airway neutrophilia in rats when administered orally.
| Keywords: | PI3K |
|---|---|
| Subjects: | C Biological Sciences > C790 Molecular Biology, Biophysics and Biochemistry not elsewhere classified |
| Divisions: | College of Science > School of Life Sciences |
| Related URLs: | |
| ID Code: | 33955 |
| Deposited On: | 13 Nov 2018 15:20 |
Repository Staff Only: item control page